发布日期：2014-10-31
英文标题：American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
来源：Gastroenterology, 2015, 148(1): 215-219
This document presents the official recommendations of the American Gastroenterological Association (AGA) on the prevention and treatment of hepatitis B virus reactivation (HBVr) during immunosuppressive therapy. The guideline was developed by the Clinical Practice and Quality Measures Committee (currently the Clinical Practice Guideline Committee) and approved by the AGA Governing Board.
